mgiuliani
Long

BIOGEN (BIIB)

NASDAQ:BIIB   BIOGEN INC
74 2 11
We think the company has a above average capital gains return. The comèany has taken a lot of debt, and we belive that that debt will be used soon to make an acquisition. Potential target is Shire Pharma             .

Related Ideas

mgiuliani
EURUSD
mgiuliani about EURUSD 1 5 months ago
mgiuliani
S&P500 (SPX)
mgiuliani about SPX 5 6 months ago
mgiuliani
4 months ago
IMPORTANT:
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
If you find useful my analysis, please hit the LIKE button and follow me.
Reply
mgiuliani
4 months ago
Target reached on 2nd of August
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out